Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06079970

Bronchoscopy With and Without Needle-based Confocal Laser Endomicroscopy for Peripheral Lung Nodule Diagnosis: Protocol for a Multicenter Randomized Controlled Trial (CLEVER Trial)

Led by Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC) · Updated on 2026-04-07

208

Participants Needed

5

Research Sites

N/A

Total Duration

On this page

Sponsors

A

Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)

Lead Sponsor

M

Mauna Kea Technologies

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating whether adding needle-based confocal laser endomicroscopy (nCLE) imaging to standard diagnostic bronchoscopy improves the ability to diagnose suspected malignant peripheral lung nodules. This trial addresses the challenge of diagnosing lung lesions that are difficult to see with regular bronchoscopy, aiming to increase the rate of definitive diagnosis by providing real-time microscopic imaging during tissue sampling. Participants will undergo bronchoscopy that includes standard techniques such as radial endobronchial ultrasound (r-EBUS) and may include fluoroscopy, electromagnetic navigation, virtual bronchoscopy, or ultrathin scopes. The study compares two groups: one receiving conventional bronchoscopy with nCLE imaging integrated before transbronchial needle aspiration (TBNA) to guide needle placement, and a control group receiving conventional bronchoscopy without nCLE. Needle positioning may be adjusted based on nCLE feedback in the study arm to potentially improve diagnostic yield. During the study, participants will have tissue samples collected via bronchoscopy with or without nCLE guidance. Researchers will evaluate diagnostic yield, sensitivity, procedure duration, needle repositioning frequency, fluoroscopy exposure, and complication rates. Follow-up is planned up to six months after bronchoscopy to assess diagnostic outcomes and need for additional diagnostics. The total anticipated study duration is about two years, with ongoing monitoring of safety and diagnostic effectiveness.

CONDITIONS

Brief Title

Confocal Laser Endomicroscopy VERification

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years of age or older
  • Suspected malignant peripheral lung lesion requiring bronchoscopic diagnosis
  • Bronchus sign on CT or confidence in navigation to nodule with r-EBUS signal
  • Solid part of the lesion at least 10 mm
  • Largest lesion dimension on CT 30 mm or less
  • Ability to understand and willingness to sign informed consent
Not Eligible

You will not qualify if you...

  • Unable or unwilling to provide informed consent
  • Visible malignancy inside the bronchi on inspection
  • Lesion accessible by linear EBUS scope
  • Non-compliance with study protocol
  • Known allergy or risk of allergic reaction to fluorescein
  • Pregnancy or breastfeeding
  • Hemodynamic instability
  • Refractory low oxygen levels
  • Use of anticoagulants that cannot be paused before procedure
  • Unable to tolerate general anesthesia
  • Currently undergoing chemotherapy with drugs affecting fluorescence (e.g., doxorubicin)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - Day of bronchoscopy procedure

Participants undergo diagnostic bronchoscopy with or without the addition of needle-based confocal laser endomicroscopy (nCLE) to analyze peripheral lung nodules.

1 procedure visit (in-person)

Long-term Monitoring

Duration - Up to 6 months

Participants are followed for up to 6 months after bronchoscopy to assess diagnostic outcomes and any additional diagnostics needed.

Follow-up visits as needed during 6 months

Trial Site Locations

Total: 5 locations

1

Montefiore Medical Center

New York, New York, United States, 10467

Actively Recruiting

2

Vienna General Hospital

Vienna, Austria

Actively Recruiting

3

General University Hospital Prague

Prague, Czechia

Actively Recruiting

4

Sotiria Hospital

Athens, Greece

Actively Recruiting

5

Amsterdam University Medical Centers

Amsterdam, Netherlands, 1081 HV

Actively Recruiting

Loading map...

Research Team

S

Saskia van Heumen, MSc

J

Jouke Annema, Prof. dr.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Similar Trials

Preoperative 3-D Virtual Resection Predicts Lung Function Af...

Non-small Cell Lung Cancer

Actively Recruiting

1 location

Toward Precision Radiotherapy: Physiological Modeling of Res...

Healthy Volunteers

Actively Recruiting

1 location

KEYMAKER-U01 Substudy 01F: A Phase 1b/2 Study of MK-1084 Wit...

Lung Neoplasm Malignant

Actively Recruiting

18 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Bronchoscopic needle-based confocal laser endomicroscopy (nCLE) as a real-time detection tool for peripheral lung cancer.

Tess Kramer, Lizzy Wijmans, Martijn de Bruin...

https://pubmed.ncbi.nlm.nih.gov/34172559

Bronchoscopy with and without needle-based confocal laser endomicroscopy for peripheral lung nodule diagnosis: protocol for a multicentre randomised controlled trial (CLEVER trial).

Saskia van Heumen, Tess Kramer, Daniël A Korevaar...

https://pubmed.ncbi.nlm.nih.gov/38964802